![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | IC50 | 27.1 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | Ki | 2.3 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_1a2ef0969fddb77e7c383253c8b871b7.svg) | Clonidine | Ki | 9.33 [1], 30.0 [2], 56.23 [3], 160.0 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_1726a98f5c906c983c15d93ec617b7f6.svg) | Terazosin | Ki | 78.0 [1], 170.0 [2], 213.0 [3], 223.87 [4], 878.0 [5] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_19486e79148b6b1ab710f15154d58c1f.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.5 [1], 4.8 [2], 6.2 [3], 8.8 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | IC50 | 42.66 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | Ki | 3.8 [1], 26.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_7b0a378e6eb6435a9af3ef94b5296f14.svg) | Idazoxan | IC50 | 53.7 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_7b0a378e6eb6435a9af3ef94b5296f14.svg) | Idazoxan | Ki | 17.78 [1], 19.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_2631acefb622fef6f50e00597cf689fd.svg) | 2-[1-(2-Prop-2-enylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 85.11 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_628cf5c819819c75fc97c108403b82dd.svg) | Methyl 5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 370.0 [1], 371.54 [2], 912.0 [3], 1320.0 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_215a9931cb11cf1c644271d4a487d831.svg) | 2-[1-(2-Biphenylyloxy)ethyl]-2-imidazoline | Ki | 199.53 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_8b7abc48edf30a2538d03e3d1bf746fe.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-2-methyl-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.1 [1], 0.2 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_79bd9e6d4ab943f8b2cd1d58bcadd7d7.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylbut-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.2 [1], 0.6 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | Ki | 1.14 [1], 2.9 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | Ki | 1.39 [1], 3.2 [2], 10.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | Ki | 77.0 [1], 82.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_ebac36f7213da3162d29205ab4152aca.svg) | Prazosin | Ki | 24.0 [1], 94.0 [2], 95.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_e684ff905325760b5d18575644f1108f.svg) | Phentolamine | Ki | 8.4 [1], 16.0 [2], 80.3 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_ea0f5584ab0c621398ec482f268c656f.svg) | Oxymetazoline | Ki | 1.0 [1], 58.88 [2], 383.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_aa21024c09830ea2a641fb75928c2842.svg) | 3-[2-[1-(4,5-Dihydro-1H-imidazol-2-yl)ethoxy]phenyl]phenol | Ki | 17.78 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_92d0f3c9cc971f2e63f8616b5df30b68.svg) | 2-[1-[2-(3-Nitrophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 234.42 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_ea6cb83269b6a18e3c0ec5ba6f4d99ca.svg) | 2-[(1S)-1-(2-Prop-2-enylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 70.79 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_024da52c2da9515a55d1fb877fe1584a.svg) | 2-[(1R)-1-(2-Prop-2-enylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 177.83 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_3573f5c91adad946c6bf8cec81498164.svg) | 2-[1-[2-(Cyclopropylmethyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 275.42 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_712d7bf3cb291229e4b03575585bc48f.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methylquinoxalin-6-amine | Ki | 27.0 [1], 28.18 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_9f23f1177b91903791ed61e0631346ce.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.8 [1], 3.1 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 61.1 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_822ed9ddbb0a07c5a21db2f3d121f745.svg) | Rauwolscine | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_822ed9ddbb0a07c5a21db2f3d121f745.svg) | Rauwolscine | Ki | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_841aee148f923620dd466429acf932bb.svg) | Mirtazapine | IC50 | 199.53 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_841aee148f923620dd466429acf932bb.svg) | Mirtazapine | Ki | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_6bd8428f24df55bebd5446ef40e0614c.svg) | Brimonidine | Ki | 44.0 [1], 83.18 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_cff59dd686ac48dc984e2eb35145cf4a.svg) | Rilmenidine | Ki | 12.59 [1], 288.4 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_99243ad70f3782906d99e25d725ca7ff.svg) | Clemastine | Ki | 14.0 [1], 223.87 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_5216a3e2c19e603317cf33ffb19df9ac.svg) | Cirazoline | Ki | 549.54 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_45dcbd1bf64013c2b1cc683f9b147e16.svg) | Niguldipine | Ki | 330.0 [1], 370.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_35189598ddecb63ddaf2b7cf9d358a69.svg) | Unii-22xbk6DY1E | Ki | 64.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_a5bf929026f27182c0c333fec96ff5ad.svg) | N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine | Ki | 27.99 [1], 28.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_7e67dc53b9dda9b460fb3afbfa5076d7.svg) | N,N-Diallyl-5-methoxytryptamine | Ki | 501.19 [1], 1479.11 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_a78a0ed3b04c8d4ec1e30e8c5a15bab6.svg) | 2,6,3,5-Ethanediylidenepentaleno(1,6-bc)pyrrol-2(1H)-ol, octahydro-1-(phenylmethyl)- | Ki | 682.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_64ef923c303f14c5288691bd20a22703.svg) | 1H-Imidazole, 4,5-dihydro-2-(1-phenoxyethyl)- | Ki | 263.03 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_ed0696f4063527c90599e250ac09b094.svg) | 2-(1-Benzofuran-6-yl)-N-[[(1R)-5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl]methyl]-N-methylethanamine | Ki | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_d437957d57f44fa0f5f8fd94263fc957.svg) | 9-Acridinamine, N-(4-(4-ethyl-1-piperazinyl)phenyl)- | Ki | 36.98 [1], 37.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_08b46e5e80d2268daf81e1bf795cc080.svg) | [4-(4-Methylpiperazinyl)phenyl]-4-quinolylamine | Ki | 1698.24 [1], 1700.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4a13570c4106131c22ba887ec7fdec50.svg) | 2-[(1S)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 302.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_d70a81e024e37dc8dc5b94ad4f093ec9.svg) | N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 1862.09 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_9bc49b50df2b2aec932f139a88a8441a.svg) | 4-(5-Fluoro-2-indanylmethyl)-2-imidazoline | Ki | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_f55cc3c3d081e9b01c9a5590a44a3b44.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-3-N,2,6-trimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 323.0 [1], 323.59 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_8f7bb7171dc7072740515ad7d2657803.svg) | 2-[(1R)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 977.24 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_353de4856aad482e432e828dd0efa8b5.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 165.0 [1], 323.59 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_f001dbd88dc07d722a8f1383953f630c.svg) | [4-(3,4-Dimethylpiperazin-1-yl)phenyl]-(2,3,7-trimethylquinolin-4-yl)amine | Ki | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_bc4cf028be868f35ddc191622d140640.svg) | {4-[4-(3,4-Dimethylpiperazin-1-yl)phenylamino]-2-methylquinolin-3-yl}methanol | Ki | 7.5 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_8e6fd1fe742aa1ca42aaae6e6344bf70.svg) | N-[4-(1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazin-2-yl)phenyl]-2,3-dimethylquinolin-4-amine | Ki | 2.3 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_6bbc6c73fa3c684f7de427f97a62e8e8.svg) | [4-(3,4-Dimethylpiperazin-1-yl)phenyl]-(2-methyl-3-phenylquinolin-4-yl)amine | Ki | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4a180f9437148bfbce51b496fdd5394b.svg) | (3-Ethyl-2-methylquinolin-4-yl)-[4-(4-methylpiperazin-1-yl)-phenyl]amine | Ki | 25.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_0bf5c9ebc4da96db85b009a6e5443b36.svg) | (2,3-Dimethylquinolin-4-yl)-[4-(4-methylpiperazin-1-yl)phenyl] amine | Ki | 34.99 [1], 35.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_164e3c953e9e1e810c3c9f23d5960c3d.svg) | (3-Isopropyl-2-methylquinolin-4-yl)-[4-(4-methylpiperazin-1-yl)phenyl]amine | Ki | 52.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_addd3ac7abbed47ac435f2cb867e41f9.svg) | {7-Chloro-4-[4-(3,3,4-trimethylpiperazin-1-yl)phenylamino]-quinolin-3-yl}methanol | Ki | 5.9 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_dac430ec9543a8c018cadc4964815292.svg) | {4-[4-(3,4-Dimethylpiperazin-1-yl)phenylamino]-6-fluoroquinolin-3-yl}methanol | Ki | 42.95 [1], 43.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_9e550292df88aa99f1de3b3f02dd1c60.svg) | 7-Chloro-N-[4-(3,4-dimethylpiperazin-1-yl)phenyl]-2,3-dimethylquinolin-4-amine | Ki | 8.3 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4c5dec0fe01168ca0f2a2e32d0a5eeca.svg) | (2-Methyl-3-phenylquinolin-4-yl)-[4-(4-methylpiperazin-1-yl)-phenyl]amine | Ki | 34.99 [1], 35.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_7244825858374a573f93016008850fb6.svg) | [4-(3,4-Dimethylpiperazin-1-yl)phenyl]-(2,3,7,8-tetramethylquinolin-4-yl)amine | Ki | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_de42c2a0ed226113125499d9de7f1c40.svg) | (3-Methylquinolin-4-yl)-[4-(3,3,4-trimethylpiperazin-1-yl)phenyl]amine | Ki | 5.39 [1], 5.4 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_7e02e6eb24af188190dcbf49d21de57f.svg) | {4-[4-(3,3,4-Trimethylpiperazin-1-yl)phenylamino]quinolin-3-yl}methanol | Ki | 6.4 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_bf6f73306995ede0bec1246bb2cd1927.svg) | {6-Fluoro-4-[4-(3,3,4-trimethylpiperazin-1-yl)phenylamino]-quinolin-3-yl}methanol | Ki | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_c6e8b27d5f47c9da347139aa6c863a6c.svg) | 1-Benzyl-4-chroman-2-ylmethyl-piperazine | Ki | 19.6 [1], 21.1 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_0782d21c3b55c3b9637817bff3561d2a.svg) | 2-[1-[2-(3-Fluorophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 16.98 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4c9db4c3c8c989bcac7236e470fb26f8.svg) | 3-[2-[1-(4,5-Dihydro-1H-imidazol-2-yl)ethoxy]phenyl]pyridine | Ki | 64.57 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_660508df601529abf07204cf1202157f.svg) | 2-[1-(2-Thiophen-3-ylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 131.83 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_6b35e5cf0bed3b55f56a1be77c3cdabe.svg) | [4-(3,4-Dimethylpiperazin-1-yl)phenyl]-(2,3,5,7-tetramethylquinolin-4-yl)amine | Ki | 132.0 [1], 132.13 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_617a2a15d1c9184b81dcb8f1e5dbee8c.svg) | N-[4-[(3S)-3,4-Dimethylpiperazin-1-yl]phenyl]-2,3,7,8-tetramethylquinolin-4-amine | Ki | 83.95 [1], 84.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_189527d6481de8824ad3e6944aa61095.svg) | N-[4-[(3R)-3,4-Dimethylpiperazin-1-yl]phenyl]-2,3,7-trimethylquinolin-4-amine | Ki | 8.3 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_d23216bc4d4db8f5d0534944ff749dcb.svg) | N-[4-(3,4-Dimethylpiperazin-1-yl)phenyl]-2,3,8-trimethylquinolin-4-amine | Ki | 6.9 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_1e49327fd317eec378517ad7f5006b7b.svg) | N-[4-(3,4-Dimethylpiperazin-1-yl)phenyl]-2,3,5,8-tetramethylquinolin-4-amine | Ki | 389.94 [1], 390.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_0ee7091be4710d64a97cf354528fd380.svg) | (5-Chloro-2,3-dimethylquinolin-4-yl)-[4-(3,4-dimethylpiperazin-1-yl)phenyl]amine | Ki | 134.9 [1], 135.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4e98b337e288f7da5a00b8ee289be6fb.svg) | 2,3,8-Trimethyl-N-[4-(3-methyl-1,3-diazinan-1-yl)phenyl]quinolin-4-amine | Ki | 770.0 [1], 5000.35 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_d368fcc7ea1457c850a59ef1db9a48ae.svg) | 4-N-(2,3-Dimethylquinolin-4-yl)-1-N-(2-pyrrolidin-1-ylethyl)benzene-1,4-diamine | Ki | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4a44f9f357eab594822eca093c8e3253.svg) | [4-[4-[(3R)-3,4-Dimethylpiperazin-1-yl]anilino]-3-methylquinolin-2-yl]methanol | Ki | 8.99 [1], 9.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_4da0514919e393eba6ae60e404c46215.svg) | (R)-{4-[4-(3,4-Dimethylpiperazin-1-yl)phenylamino]quinolin-3-yl}methanol | Ki | 9.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_b0fe642f74ece69597d5332107b252e4.svg) | (3-Benzyl-2-methylquinolin-4-yl)-[4-(4-methylpiperazin-1-yl)-phenyl]amine | Ki | 34.99 [1], 35.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_af14e674133236b72d57543cf917124d.svg) | [4-(3,4-Dimethylpiperazin-1-yl)phenyl]-(3-methylquinolin-4-yl)amine | Ki | 8.49 [1], 8.5 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_6265c4417e95a24a7924a6d5ea564a22.svg) | N-[4-[(3R)-3,4-Dimethylpiperazin-1-yl]phenyl]-2,3,7,8-tetramethylquinolin-4-amine | Ki | 7.69 [1], 7.7 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_61ca0125e5535ae2478faee14b49118c.svg) | N-[4-[(3S)-3,4-Dimethylpiperazin-1-yl]phenyl]-2,3,7-trimethylquinolin-4-amine | Ki | 76.0 [1], 76.03 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_1c471a08243068802cf60becbaef1bbc.svg) | [4-(3,4-Dimethylpiperazin-1-yl)phenyl]-(2,3,5-trimethylquinolin-4-yl)amine | Ki | 87.0 [1], 87.1 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_6af4f2cc25ce1b96158e786e12f77d6b.svg) | N-[4-(3,4-Dimethylpiperazin-1-yl)phenyl]-6-fluoro-2,3-dimethylquinolin-4-amine | Ki | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_03b754384f3f647a1d3880eaaa8c969d.svg) | 1-N-[2-(Diethylamino)ethyl]-4-N-(3-ethyl-2,8-dimethylquinolin-4-yl)benzene-1,4-diamine | Ki | 82.0 [1], 82.04 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_9857a89a1e006857d652e5344d9fa17e.svg) | (3-Ethyl-2,8-dimethylquinolin-4-yl)-[4-(4-methyl-[1,4]diazepan-1-yl)phenyl]amine | Ki | 8.49 [1], 8.5 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_f66ff11598a7d1d89b71ed2972508e75.svg) | [2-Methyl-4-[4-(3,3,4-trimethylpiperazin-1-yl)anilino]quinolin-3-yl]methanol | Ki | 3.8 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_7275a7290ce696d72c512b780635e63d.svg) | 1-[4-[4-(3,4-Dimethylpiperazin-1-yl)anilino]-2-methylquinolin-3-yl]ethanol | Ki | 4.9 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_8be3de1737a1adac8340a698731f2565.svg) | (R)-{4-[4-(3-Methylpiperazin-1-yl)phenylamino]quinolin-3-yl}methanol | Ki | 205.0 [1], 205.12 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_40ba48c7708a59e809940cb9632bb96a.svg) | [4-[4-[(3R)-3,4-Dimethylpiperazin-1-yl]anilino]-6-fluoroquinolin-3-yl]methanol | Ki | 38.0 [1], 38.02 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_0e92214b0de4a5d831c13465ae72f990.svg) | (3,5-Dimethyl-pyridin-4-yl)-[4-(4-methylpiperazin-1-yl)phenyl]amine | Ki | 769.13 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_6b65751fa13a5a044fff644297fc4081.svg) | N-[4-(3,4-Dimethylpiperazin-1-yl)phenyl]-3-ethyl-2-methyl-5,6,7,8-tetrahydroquinolin-4-amine | Ki | 109.9 [1], 110.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_634f3e7a047442c41883058dc544b2e4.svg) | (3R,3As)-3-[[4-[(E)-3-(4-fluorophenyl)-2-methylprop-2-enyl]piperazin-1-yl]methyl]-7,8-dimethoxy-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.7 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_b3c827abeea9e12efe9571a0e1d4378b.svg) | (R)-3-Nitrobiphenyline | Ki | 257.04 [1], 363.08 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_774443f432049c7821df7e83f28ea2ae.svg) | 2-[(1S)-1-[2-(3-Nitrophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole | Ki | 537.03 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_00d377c7f38eeb0707ff1fb3aea8b3fc.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(Z)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 9.5 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_0a6f09d9399e627cb4c92b9f053304d0.svg) | 2-[1-(2-Cyclopropylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 79.43 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-2c-adrenergic-receptor_ee26655c5cb74fd95008137822479c1c.svg) | 2-[(1S)-1-(2-Cyclopropylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 63.1 [1] |